title: New evidence for the role of proteasome inhibitors in systemic lupus erythematosus: comment on the article by Ichikawa et al.
authors.forename: Yan
authors.initials: Y
authors.lastname: Ma
authors.forename: Wang-Dong
authors.initials: WD
authors.lastname: Xu
authors.forename: Hai-Feng
authors.initials: HF
authors.lastname: Pan
authors.forename: Dong-Qing
authors.initials: DQ
authors.lastname: Ye
mesh_terms: D000818:Animals; D000921:Antibody-Producing Cells / Q000187:drug effects*; D001897:Boronic Acids / Q000627:therapeutic use*; D006801:Humans; D007370:Interferon Type I / Q000037:antagonists & inhibitors*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008181:Lupus Nephritis / Q000188:drug therapy*; D009842:Oligopeptides / Q000627:therapeutic use*; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*
chemical_list: D001897:Boronic Acids; D007370:Interferon Type I; D009842:Oligopeptides; D011480:Protease Inhibitors; D011719:Pyrazines